Advertisements


Zynerba announces results from pivotal CONNECT-FX trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 30th, 2020

Zynerba sees topline results from CONNECT-FX trial late in Q2

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 11th, 2020

Hua Medicine Announces 2019 Annual Results

Pivotal Phase III Trial Achieved Clinical Efficacy Endpoint at 24 WeeksDorzagliatin-Driven Portfolio Expands SHANGHAI, China, March 16, 2020 (GLOBE NEWSWIRE) -- Hua Medicine (the "Company", Stock Code on The Stock Exchange of Hong Kon.....»»

Category: earningsSource: benzingaMar 16th, 2020

Zynerba provides update on pivotal CONNECT-FX trial of Zygel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 13th, 2020

Rising High: Auxly updates cultivation strategy as Zynerba reports trial results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 2nd, 2020

Zynerba plummets 51% after its CBD gel fails trial for rare disease (ZYNE)

Zynerba, a small biotechnology company, plummeted 51% on Tuesday after its CBD gel failed a pivotal trial for a rare disorder called Fragile X syndrome. The company said its.....»»

Category: smallbizSource: nytJun 30th, 2020

Iterum Therapeutics announces results from Phase 3 trial of oral sulopenem

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 29th, 2020

Immunovant Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2020 and Announces Plans for Phase 3 Registrational Trial of IMVT-1401 in Myasthenia Gravis

Based on compelling proof-of-biology for anti-FcRn agents in Myasthenia Gravis (MG), Immunovant has begun preparations to initiate a Phase 3 registrational trial of IMVT-1401 in MG IMVT-1401's development .....»»

Category: earningsSource: benzingaJun 29th, 2020

Novo Nordisk announces results from phase 2 trial of icodec

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2020

Soliton reports "positive" pivotal cellulite clinical trial results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2020

AbbVie announces results from VIALE-A trial in AML

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2020

BeyondSpring announces results of PROTECTIVE-2 Phase 2 trial for CIN

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 9th, 2020

Kezar Life Sciences announces updated results from portion of MISSION trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 3rd, 2020

Menlo Therapeutics announces results from Phase 2 trial of FCD105

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 2nd, 2020

BrainStorm announces NurOwn Phase 3 pivotal trial remains on track

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 2nd, 2020

Novus Therapeutics announces OP0201 trial results, engages financial advisor

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 1st, 2020

Gilead announces topline results from Phase 3 SIMPLE trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 1st, 2020

Aileron announces interim results from Phase 1b/2 trial of ALRN-6924

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 1st, 2020

Seattle Genetics announces results from exploratory analyses of HER2CLIMB trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2020

AstraZeneca announces results from Imfinzi plus tremelimumab trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2020

Gilead announces updated results from magrolimab trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2020